Our study demonstrated that the expression of CD105 and BMP9 is positively correlated with each other in residual choriocarcinoma cells after chemotherapy, which is closely related to recurrence, but not related to age and β-hCG levels. The gene discussed is GDF2; the disease is choriocarcinoma.